Cases of RSV and flu are ticking up among young children in the U.S. even as overall respiratory virus activity remains low, ...
Valneva reports long-lasting antibody persistence in its chikungunya vaccine three years post-dose, supporting its global ...
Travel Health Pro, a platform run by the UK Health Security, has issued an advisory to travelers to reduce the spread of ...
The deadly Marburg virus disease, similar to Ebola and is now being referred to as the Bleeding Eye Virus, is spreading ...
The Marburg virus, also known as the bleeding eye disease, is a deadly pathogen causing severe symptoms and raising global ...
With at least 15 fatalities and hundreds of infections reported across 17 African countries, including Rwanda, health ...
REUTERS /AMANDA PEROBELL / 2023 An employee dilutes poultry serum samples for ELISA test for the detection of antibodies to the avian influenza virus at the Reference Laboratory of the World ...
This is a crucial step in order to make gene therapy more effective and to increase the number of patients able to access it.
Korea Joongang Daily on MSN17 小时
Beyfortus RSV treatment to launch in Korea next month
Beyfortus, a long-acting RSV antibody treatment for infants, will launch in Korea next month, aiming to address rising ...
Antibody levels remained high at 96% seroresponse in line with the two-year persistence data This long-lasting antibody persistence was comparable in older (65+) and younger adults Saint-Herblain ...
The H5N1 bird flu outbreak in the U.S. has so far been shockingly mild. Researchers have some theories as to why.